ClinicalTrials.gg
Sign In

Hepatitis D clinical trials

The registry lists 63 studies for Hepatitis D across more than 10 countries. 21 are recruiting or about to start. 39 of them are mainly about Hepatitis D (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its narrower condition Hepatitis D, Chronic too: 95 studies, 28 open.

Get an email when these change. Save the Hepatitis D studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
22
Recruiting
14
Active, not recruiting
8
Status unknown
6
Not yet recruiting
6
Terminated
3

Phase

Phase 2
18
Phase 3
10
Phase 1
2

Where

United States
15
France
13
Italy
13
Germany
13
Romania
11
Pakistan
10

Who runs them

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (7) · Vir Biotechnology, Inc. (4) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (4) · Mirum Pharmaceuticals, Inc. (4) · Eiger BioPharmaceuticals (3) · National Taiwan University Hospital (2) · HepNet Study House, German Liverfoundation (2) · University of Alabama at Birmingham (2)

What is being tested here

Drugs under test in Hepatitis D studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Brelovitug133
Ursodeoxycholic Acid101
Libevitug111
Lonafarnib025
Tobevibart024
Elebsiran024
Ritonavir024
Peginterferon alfa-2a013
Peginterferon lambda-1a012
Ezetimibe002

Coming up

7phase 3 studies under way
6studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 14 Hepatitis D studies recruiting now, 9 (64%) set no upper age limit and 1 (7%) stop at 75 or younger. 3 (21%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (14%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
101 (7%)1 (7%)
1814 (100%)14 (100%)
3014 (100%)14 (100%)
4014 (100%)14 (100%)
5014 (100%)14 (100%)
6514 (100%)14 (100%)
7513 (93%)13 (93%)
8512 (86%)12 (86%)

Across all 63 studies, recruiting or not: 25% stop at 75 or younger and 8% at 65; 17% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 → or search them.